https://www.inspiredhygiene.com/feed&follow=1
-
STAT+: The unexpected forces behind thousands of comments about Medicare’s limits on a new Alzheimer’s drug
WASHINGTON — Medicare has already received more than 4,300 comments on its recent proposal to limit coverage for Biogen’s...
-
STAT+: A San Diego biotech’s massive valuation turned heads. Now, mass layoffs raise questions
Biosplice, once the world’s most valuable biotech startup, is laying off nearly a quarter of its workforce and has stopped internal...
-
Opinion: Development of clinical practice guidelines ‘is a mess’
The world of clinical practice guidelines is a mess. Regardless of what medical field you look at — oncology, cardiology, urology...
-
Opinion: Medicare can help fix the nurse shortage in hospitals
There’s no polite way to say this: The U.S. health care system failed the American people during the Covid-19 pandemic. Unless we admit to...
-
‘Good, not great’: Some long Covid patients see their symptoms improve, but full recovery is elusive
How long does long Covid last? And what does it mean to achieve full recovery? If you ask Joni White, she’ll tell you she just wants to...
-
STAT+: Health insurers, turning to tech to pinpoint needy patients, risk leaving some behind
Health insurers are leaning more heavily on machine learning to predict which patients will miss out on care because they can’t get a ride...
-
Eric Lander resigns — potentially imperiling the rest of Biden’s scientific agenda
WASHINGTON — When President Biden tapped Eric Lander as White House science adviser in January 2021, he tasked the renowned genomics...
-
STAT+: ‘Caught in the middle’: Some patients say they’ve lost out in unusual battle over a rare disease drug
An unusual, decade-long fight over an orphan drug market appears to be at an end after a small, family-run company was defeated in a bruising...
-
STAT+: In a victory for medical journals, Pacira loses a libel lawsuit over ‘faulty scientific research’ allegations
A federal judge has dismissed an unusual libel lawsuit brought by Pacira BioSciences ( PCRX ) that claimed a medical journal, its editor, and...
-
Walking again after paralysis: Early study suggests stimulation could jolt spinal cord back to life
After a traumatic motorcycle collision in 2017, Michel Roccati was left completely paralyzed from the waist down. He couldn’t have imagined...
-
Virtual Event: The exhaustion epidemic: Examining the Covid-19 burnout crisis in health care
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. The coronavirus pandemic has left health care workers...
-
STAT+: Pharmalittle: Pressure campaign grows to confirm Califf as FDA head; FDA regulator skeptical of Lilly drug licensed from China
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that...
-
Opinion: The Supreme Court is partly to blame for the Covid-19 test kit shortage
Many pharmacies across the nation are sold out of Covid-19 rapid diagnostic tests, making it exceedingly difficult for Americans to contain the...
-
Opinion: STAT+: Manufacturing at the edge: smaller, localized, and agile factories will be key to biopharma drug production
Pharmaceutical manufacturing has had to navigate transformational changes during the pandemic, just like many other industrial sectors. Demand for...
-
STAT+: The quest for the small molecule holy grail with Merck’s head of R&D
Scientists at Merck are staring down a drug development puzzle. One that has to do with a mutated protein called PCSK9, which is associated with...
-
STAT+: In a bid to save Biden’s FDA pick, doctors and public health groups are mounting a rare pressure campaign
WASHINGTON — Some of the nation’s most influential doctors and public health groups are orchestrating a mad-dash effort to convince...
-
Lander’s all-staff mea culpa is the latest in a string of apologies
WASHINGTON — It wasn’t his first apology. But the sweeping mea culpa that Eric Lander issued this past week might have been his...
-
Opinion: Mrs. J wanted a blanket in the emergency department. Saying no chips away at my soul
What upsets Mrs. J isn’t the six hours she’s waited in the emergency department to see a doctor for a growing and surprisingly...
-
Opinion: Cancer moonshot 2.0: A missed opportunity for prevention
President Biden’s new initiative to “reignite the cancer moonshot” proposes the laudable goal of cutting the cancer death...
-
STAT+: FDA’s top cancer regulator gives cool reception to drug Lilly licensed from Chinese drugmaker
A Food and Drug Administration meeting scheduled for next week to review a Chinese-developed cancer immunotherapy is likely to be challenging for...
-
Study suggests Omicron-specific booster may not provide more protection
A new study conducted in primates suggests there may not be a benefit from updating Covid-19 vaccines to target the Omicron variant at this time....
-
STAT+: Biden’s FDA pick Califf vows to reform accelerated approvals to win a key senator’s support
WASHINGTON — President Biden’s pick to lead the Food and Drug Administration promised a key senator that he will crack down on drug...
-
Opinion: High-risk individuals should get priority access to Covid therapies. That isn’t happening
Ms. S, a primary care patient in one of our clinics (M.L.B.), recently called in with loss of taste and a terrible cough, worse than her regular...
-
STAT+: Pharmalittle: SEC and FTC open probes into Biogen; South Africa’s Afrigen makes its own version of Moderna Covid shot
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream...
-
Opinion: Primary care clinicians are the glue to health and wellness. Their shortage spells trouble
The pandemic has taught us about an economic and logistic concept that most people take for granted, if they’ve even thought about it at...